60.99

7.40% +4.20

Korro Bio Inc. (KRRO)

Overview News Price History Discussions Forecast

Korro Bio Inc. stock is currently priced at $60.99, with a 24-hour trading volume of 32,168. It has seen a +7.40% increased in the last 24 hours and a -32.04% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $57.77 pivot point. If it approaches the $63.50 resistance level, significant changes may occur.

Previous Close:

$56.79

Open:

$55

24h Volume:

32,168

Market Cap:

$565.54M

Revenue:

Net Income/Loss:

$-81.17M

P/E Ratio:

EPS:

Net Cash Flow:

$-75.12M

1W Performance:

-3.18%

1M Performance:

-32.04%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$54.44

$61.49

52W Range:

$34.07

$97.91

Korro Bio Inc. Stock (KRRO) Company Profile

Name

Korro Bio Inc.

Sector

Healthcare (1189)

Industry

Biotechnology (685)

Phone

781-315-4600

Address

One Kendall Square, Building 600-700 Suite 6-401, Cambridge

Employee

Twitter

Next Earnings Date

2024-05-15

Latest SEC Filings

KRRO's Discussions on Twitter

Korro Bio Inc. Stock (KRRO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-28-24	Reiterated	H.C. Wainwright	Buy
Feb-27-24	Initiated	BMO Capital Markets	Outperform
Dec-04-23	Initiated	H.C. Wainwright	Buy
Nov-29-23	Initiated	RBC Capital Mkts	Outperform
Nov-10-23	Initiated	Piper Sandler	Overweight
Feb-15-23	Downgrade	Chardan Capital Markets	Buy → Neutral
Feb-13-23	Downgrade	Cowen	Outperform → Market Perform
Sep-22-21	Downgrade	Goldman	Buy → Neutral
Jan-27-21	Upgrade	JP Morgan	Neutral → Overweight
Dec-22-20	Initiated	B. Riley Securities	Buy
Jul-14-20	Initiated	Oppenheimer	Outperform
May-18-20	Downgrade	JP Morgan	Overweight → Neutral
Oct-28-19	Initiated	Cowen	Outperform
Oct-28-19	Initiated	Goldman	Buy
Oct-28-19	Initiated	JP Morgan	Overweight

View All

Korro Bio Inc. Stock (KRRO) Latest News

Wall Street Analysts Believe Korro Bio, Inc. (KRRO) Could Rally 86.94%: Here's is How to Trade

Zacks Investment Research

Best Momentum Stocks to Buy for February 16th

Zacks Investment Research

New Strong Buy Stocks for February 16th

Zacks Investment Research

Korro Bio Inc. Stock (KRRO) Financials Data

Korro Bio Inc. (KRRO) Net Income 2024

KRRO net income (TTM) was -$81.17 million for the quarter ending December 31, 2023.

Korro Bio Inc. (KRRO) Cash Flow 2024

KRRO recorded a free cash flow (TTM) of -$75.12 million for the quarter ending December 31, 2023.

Korro Bio Inc. (KRRO) Earnings per Share 2024

KRRO earnings per share (TTM) was -$10.13 for the quarter ending December 31, 2023.

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.